Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedtime vs morning low-dose aspirin and circadian rhythm of platelet function in healthy subjects
2013-001410-16Phase 4Active
- Sponsor
- Nederlandse Hartstichting
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aspirin (2 arms), sponsored by Nederlandse Hartstichting. Primary endpoint: platelet reactivity (VerifyNow aspirin). Started Jun 2013; status: active.
02
Drugs
aspirin
Beyond the preview
Go deeper on 2013-001410-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001410-16.